Company Overview
- Website
- nodthera.com
- Phone
- (617) 866-7350
- Employees
- 4
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
NodThera Announces Appointment of Elisabeth Björk as Board Member
- Jun 17, 2025
- finance.yahoo.com
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
- Jun 4, 2025
- uk.finance.yahoo.com
NodThera Charts Obesity Future with First Patients Dosed in
- Jun 4, 2025
- globenewswire.com
The NLRP3 inhibitor NT-0796 enhances and sustains GLP-1R agonist-mediated weight loss in a murine diet-induced obesity model
- Apr 30, 2025
- onlinelibrary.wiley.com
NodThera’s Oral NLRP3 Inhibitor NT-0796 Enhances and Sustains Weight Loss in Combination with GLP-1
- Apr 30, 2025
- globenewswire.com
The Future Of Inflammation: The Inflammasome And Beyond
- Nov 13, 2024
- insights.citeline.com
Company Leadership
Companies Similar to NodThera
Analyze industry trends and opportunities by examining competitors and companies comparable to NodThera, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |